- Home
- GANX vs MODV Comparison
GANX vs MODV Comparison
Compare GANX & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- MODV
- Stock Information
- Founded
- GANX 2017
- MODV 1996
- Country
- GANX United States
- MODV United States
- Employees
- GANX N/A
- MODV N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- GANX Health Care
- MODV Consumer Discretionary
- Exchange
- GANX Nasdaq
- MODV Nasdaq
- Market Cap
- GANX 51.8M
- MODV 43.6M
- IPO Year
- GANX 2021
- MODV N/A
- Fundamental
- Price
- GANX $1.44
- MODV $2.70
- Analyst Decision
- GANX Strong Buy
- MODV Buy
- Analyst Count
- GANX 5
- MODV 4
- Target Price
- GANX $8.20
- MODV $9.17
- AVG Volume (30 Days)
- GANX 275.2K
- MODV 503.7K
- Earning Date
- GANX 08-11-2025
- MODV 08-11-2025
- Dividend Yield
- GANX N/A
- MODV N/A
- EPS Growth
- GANX N/A
- MODV N/A
- EPS
- GANX N/A
- MODV N/A
- Revenue
- GANX N/A
- MODV $2,753,789,000.00
- Revenue This Year
- GANX N/A
- MODV N/A
- Revenue Next Year
- GANX N/A
- MODV $4.90
- P/E Ratio
- GANX N/A
- MODV N/A
- Revenue Growth
- GANX N/A
- MODV N/A
- 52 Week Low
- GANX $0.89
- MODV $0.87
- 52 Week High
- GANX $3.19
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- GANX 34.87
- MODV 41.85
- Support Level
- GANX $1.55
- MODV $2.88
- Resistance Level
- GANX $1.72
- MODV $3.20
- Average True Range (ATR)
- GANX 0.12
- MODV 0.26
- MACD
- GANX -0.02
- MODV -0.07
- Stochastic Oscillator
- GANX 6.12
- MODV -1.39
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.